Crossmark

Early erythrocytosis and predictors of hematocrit response after SGLT2 inhibitor initiation in type 2 diabetes

Published Online: 2026-08-27

Authors

Comoglu, Ezgi

Akdag, Seyit Ibrahim

Erkal, Ayse

Akgoz, Busra Senturk

Gemcioglu, Emin
License Information

Text and Data Mining valid from 2026-08-27

Accepted Manuscript valid from 2026-08-27
More Information

Article History

Received: 8 July 2026

Accepted: 14 August 2026

First Online: 27 August 2026

Declarations

Competing interests: The authors declare no competing interests.

Document is current